Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells

Michael G. Davis, Ming Zhou, Safdar Ali, J. Douglas Coffin, Thomas Doetschman, Gerald W. Dorn

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

In order to elucidate the effects of the different basic fibroblast growth factor (bFGF) isoforms on vascular smooth muscle, we examined aorta-derived vascular smooth muscle cells from transgenic mice expressing the human isoforms of bFGF. Four cell lines were examined from mice in which transgene expression was driven by the ubiquitous phosphoglycerate kinase promoter. Overexpression and cellular localization was confirmed by Western blot analysis in vascular smooth muscle cells from mice expressing: all four human bFGF isoforms (24, 22, 21, and 18 kDa); all three nuclear targeted isoforms (24, 22, and 21 kDa); only the 24 kDa isoform; and the only secreted/non-nuclear targeted isoform, 18 kDa. All lines showed approximate fourfold increases in bFGF expression, nuclear localization of all nuclear targeted bFGF isoforms, and cytosolic localization of only the 18 kDa bFGF. Measurement of [3H]thymidine incorporation into quiescent cells stimulated with increasing concentrations of serum, showed increased DNA synthesis in cell lines expressing any bFGF isoform when compared to non-transgenic control cells, and a further increase in DNA synthesis in cells expressing the nuclear targeted isoforms (24, 22, and 21 kDa) over the 18 kDa bFGF expressing cell line at any concentration of serum. All cells showed equal label incorporation when stimulated with 10 ng/ml of platelet-derived growth factor confirming an equal potential for DNA synthesis. Neutralizing the bFGF antibody markedly decreased serum-stimulated DNA synthesis, but only in the cell lines overexpressing the secreted/non-nuclear targeted 18 kDa isoform. These results suggest amplification of DNA synthesis through synergistic intracrine and autocrine effects of the nuclear targeted and non-nuclear targeted bFGF isoforms in vascular smooth muscle cells.

Original languageEnglish (US)
Pages (from-to)1061-1072
Number of pages12
JournalJournal of Molecular and Cellular Cardiology
Volume29
Issue number4
DOIs
StatePublished - Jan 1 1997

Fingerprint

Fibroblast Growth Factor 2
Vascular Smooth Muscle
Smooth Muscle Myocytes
Protein Isoforms
DNA
Cell Line
Serum
Phosphoglycerate Kinase
Platelet-Derived Growth Factor
Transgenes
Thymidine
Transgenic Mice
Aorta
Western Blotting

Keywords

  • Basic fibroblast growth factor
  • Transgenic mice
  • Vascular smooth muscle cell

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. / Davis, Michael G.; Zhou, Ming; Ali, Safdar; Coffin, J. Douglas; Doetschman, Thomas; Dorn, Gerald W.

In: Journal of Molecular and Cellular Cardiology, Vol. 29, No. 4, 01.01.1997, p. 1061-1072.

Research output: Contribution to journalArticle

Davis, Michael G. ; Zhou, Ming ; Ali, Safdar ; Coffin, J. Douglas ; Doetschman, Thomas ; Dorn, Gerald W. / Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. In: Journal of Molecular and Cellular Cardiology. 1997 ; Vol. 29, No. 4. pp. 1061-1072.
@article{69070ee04fba4b798b6c36740d409216,
title = "Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells",
abstract = "In order to elucidate the effects of the different basic fibroblast growth factor (bFGF) isoforms on vascular smooth muscle, we examined aorta-derived vascular smooth muscle cells from transgenic mice expressing the human isoforms of bFGF. Four cell lines were examined from mice in which transgene expression was driven by the ubiquitous phosphoglycerate kinase promoter. Overexpression and cellular localization was confirmed by Western blot analysis in vascular smooth muscle cells from mice expressing: all four human bFGF isoforms (24, 22, 21, and 18 kDa); all three nuclear targeted isoforms (24, 22, and 21 kDa); only the 24 kDa isoform; and the only secreted/non-nuclear targeted isoform, 18 kDa. All lines showed approximate fourfold increases in bFGF expression, nuclear localization of all nuclear targeted bFGF isoforms, and cytosolic localization of only the 18 kDa bFGF. Measurement of [3H]thymidine incorporation into quiescent cells stimulated with increasing concentrations of serum, showed increased DNA synthesis in cell lines expressing any bFGF isoform when compared to non-transgenic control cells, and a further increase in DNA synthesis in cells expressing the nuclear targeted isoforms (24, 22, and 21 kDa) over the 18 kDa bFGF expressing cell line at any concentration of serum. All cells showed equal label incorporation when stimulated with 10 ng/ml of platelet-derived growth factor confirming an equal potential for DNA synthesis. Neutralizing the bFGF antibody markedly decreased serum-stimulated DNA synthesis, but only in the cell lines overexpressing the secreted/non-nuclear targeted 18 kDa isoform. These results suggest amplification of DNA synthesis through synergistic intracrine and autocrine effects of the nuclear targeted and non-nuclear targeted bFGF isoforms in vascular smooth muscle cells.",
keywords = "Basic fibroblast growth factor, Transgenic mice, Vascular smooth muscle cell",
author = "Davis, {Michael G.} and Ming Zhou and Safdar Ali and Coffin, {J. Douglas} and Thomas Doetschman and Dorn, {Gerald W.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1006/jmcc.1997.0383",
language = "English (US)",
volume = "29",
pages = "1061--1072",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells

AU - Davis, Michael G.

AU - Zhou, Ming

AU - Ali, Safdar

AU - Coffin, J. Douglas

AU - Doetschman, Thomas

AU - Dorn, Gerald W.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - In order to elucidate the effects of the different basic fibroblast growth factor (bFGF) isoforms on vascular smooth muscle, we examined aorta-derived vascular smooth muscle cells from transgenic mice expressing the human isoforms of bFGF. Four cell lines were examined from mice in which transgene expression was driven by the ubiquitous phosphoglycerate kinase promoter. Overexpression and cellular localization was confirmed by Western blot analysis in vascular smooth muscle cells from mice expressing: all four human bFGF isoforms (24, 22, 21, and 18 kDa); all three nuclear targeted isoforms (24, 22, and 21 kDa); only the 24 kDa isoform; and the only secreted/non-nuclear targeted isoform, 18 kDa. All lines showed approximate fourfold increases in bFGF expression, nuclear localization of all nuclear targeted bFGF isoforms, and cytosolic localization of only the 18 kDa bFGF. Measurement of [3H]thymidine incorporation into quiescent cells stimulated with increasing concentrations of serum, showed increased DNA synthesis in cell lines expressing any bFGF isoform when compared to non-transgenic control cells, and a further increase in DNA synthesis in cells expressing the nuclear targeted isoforms (24, 22, and 21 kDa) over the 18 kDa bFGF expressing cell line at any concentration of serum. All cells showed equal label incorporation when stimulated with 10 ng/ml of platelet-derived growth factor confirming an equal potential for DNA synthesis. Neutralizing the bFGF antibody markedly decreased serum-stimulated DNA synthesis, but only in the cell lines overexpressing the secreted/non-nuclear targeted 18 kDa isoform. These results suggest amplification of DNA synthesis through synergistic intracrine and autocrine effects of the nuclear targeted and non-nuclear targeted bFGF isoforms in vascular smooth muscle cells.

AB - In order to elucidate the effects of the different basic fibroblast growth factor (bFGF) isoforms on vascular smooth muscle, we examined aorta-derived vascular smooth muscle cells from transgenic mice expressing the human isoforms of bFGF. Four cell lines were examined from mice in which transgene expression was driven by the ubiquitous phosphoglycerate kinase promoter. Overexpression and cellular localization was confirmed by Western blot analysis in vascular smooth muscle cells from mice expressing: all four human bFGF isoforms (24, 22, 21, and 18 kDa); all three nuclear targeted isoforms (24, 22, and 21 kDa); only the 24 kDa isoform; and the only secreted/non-nuclear targeted isoform, 18 kDa. All lines showed approximate fourfold increases in bFGF expression, nuclear localization of all nuclear targeted bFGF isoforms, and cytosolic localization of only the 18 kDa bFGF. Measurement of [3H]thymidine incorporation into quiescent cells stimulated with increasing concentrations of serum, showed increased DNA synthesis in cell lines expressing any bFGF isoform when compared to non-transgenic control cells, and a further increase in DNA synthesis in cells expressing the nuclear targeted isoforms (24, 22, and 21 kDa) over the 18 kDa bFGF expressing cell line at any concentration of serum. All cells showed equal label incorporation when stimulated with 10 ng/ml of platelet-derived growth factor confirming an equal potential for DNA synthesis. Neutralizing the bFGF antibody markedly decreased serum-stimulated DNA synthesis, but only in the cell lines overexpressing the secreted/non-nuclear targeted 18 kDa isoform. These results suggest amplification of DNA synthesis through synergistic intracrine and autocrine effects of the nuclear targeted and non-nuclear targeted bFGF isoforms in vascular smooth muscle cells.

KW - Basic fibroblast growth factor

KW - Transgenic mice

KW - Vascular smooth muscle cell

UR - http://www.scopus.com/inward/record.url?scp=0031127629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031127629&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1997.0383

DO - 10.1006/jmcc.1997.0383

M3 - Article

C2 - 9160859

AN - SCOPUS:0031127629

VL - 29

SP - 1061

EP - 1072

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 4

ER -